Fig. 4From: Survival outcomes of neoadjuvant versus adjuvant chemotherapy in triple-negative breast cancer: a meta-analysis of 36,480 casesForest plot of the HR for OS in TNBC patients for NACT vs. ACT (a), NACT with pCR vs. ACT (b), and NACT with RD vs. ACT (c)Back to article page